GlassScriptPhysician profile
Hemantha Koduri
NPI 1912055112
$9,993.56
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $784 · 2020: $3,228 · 2021: $610 · 2022: $2,005 · 2023: $2,910 · 2024: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,952 · Food and Beverage: $1,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,952.45 |
| Food and Beverage | $1,414.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $2,474.35 | 2020 | |
| Medtronic, INC. | $2,361.77 | 2023 | Onyx Frontier, Resolute Onyx, Telescope |
| Abbott Laboratories | $1,723.30 | 2019-2022 | |
| Boston Scientific Corporation | $794.99 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Bodyguardian |
| Astellas Pharma US INC | $374.17 | 2019-2021 | |
| Cardiovascular Systems INC. | $365.60 | 2020 | |
| Pfizer INC. | $292.61 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $281.26 | 2021-2024 | |
| Amgen INC. | $273.72 | 2019-2023 | Repatha |
| Impulse Dynamics (USA) INC. | $150.40 | 2023-2024 | Optimizer, Optimizer |
| Itamar Medical INC | $103.65 | 2022-2023 | Watchpatone |
| Esperion Therapeutics, INC. | $98.06 | 2020-2023 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $74.88 | 2019-2023 | Camzyos |
| Janssen Pharmaceuticals, INC | $66.94 | 2020-2023 | Xarelto |
| Sanofi-Aventis U.S. LLC | $64.91 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $56.17 | 2019-2020 | |
| Philips North America LLC | $50.32 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $45.59 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.42 | 2019-2024 | Jardiance |
| Lundbeck LLC | $35.50 | 2019-2020 | |
| Kiniksa Pharmaceuticals, LTD. | $32.15 | 2023 | Arcalyst |
| Amarin Pharma, INC. | $29.84 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $27.79 | 2021 | |
| Gilead Sciences, INC. | $24.81 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $24.43 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.71 | 2024 | Lifevest |
| Angiodynamics, INC. | $19.31 | 2022 | |
| Novo Nordisk INC | $16.25 | 2024 | Wegovy |
| Arbor Pharmaceuticals, INC. | $14.55 | 2019 | |
| Merck Sharp & Dohme LLC | $14.29 | 2023 | Verquvo |
| Baxter Healthcare | $13.88 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $13.50 | 2023 | Inpefa |
| Jazz Pharmaceuticals INC. | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hemantha Koduri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.